{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:35:51Z","timestamp":1793385351009,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T00:00:00Z","timestamp":1692921600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.eururo.2023.07.014","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T22:15:15Z","timestamp":1694816115000},"page":"82-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Field Cancerization Is Associated with Tumor Development, T-cell Exhaustion, and Clinical Outcomes in Bladder Cancer"],"prefix":"10.1016","volume":"85","author":[{"given":"Trine","family":"Strandgaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iver","family":"Nordentoft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Birkenkamp-Demtr\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liina","family":"Salminen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Prip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tine Ginnerup","family":"Andreasen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sia Viborg","family":"Lindskrog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emil","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Lamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torben","family":"Steiniche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rgen Bjerggaard","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7061-9851","authenticated-orcid":false,"given":"Lars","family":"Dyrskj\u00f8t","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2023.07.014_b0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrc.2017.102","article-title":"An evolutionary perspective on field cancerization","volume":"18","author":"Curtius","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.eururo.2023.07.014_b0010","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/modpathol.2014.81","article-title":"Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression","volume":"28","author":"Lochhead","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.eururo.2023.07.014_b0015","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3233\/BLC-200282","article-title":"Mutational analysis of field cancerization in bladder cancer","volume":"6","author":"Strandgaard","year":"2020","journal-title":"Bladder Cancer"},{"key":"10.1016\/j.eururo.2023.07.014_b0020","doi-asserted-by":"crossref","first-page":"5894","DOI":"10.1158\/0008-5472.CAN-16-0436","article-title":"Paired exome analysis reveals clonal evolution and potential therapeutic targets in urothelial carcinoma","volume":"76","author":"Lamy","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.eururo.2023.07.014_b0025","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.celrep.2014.04.038","article-title":"Mutational context and diverse clonal development in early and late bladder cancer","volume":"7","author":"Nordentoft","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.eururo.2023.07.014_b0030","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.semcancer.2006.02.002","article-title":"Bladder cancer, a two phased disease?","volume":"17","author":"H\u00f6glund","year":"2007","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.eururo.2023.07.014_b0035","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1126\/science.aba8347","article-title":"Extensive heterogeneity in somatic mutation and selection in the human bladder","volume":"370","author":"Lawson","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.eururo.2023.07.014_b0040","doi-asserted-by":"crossref","first-page":"104551","DOI":"10.1016\/j.isci.2022.104551","article-title":"The origin of bladder cancer from mucosal field effects","volume":"25","author":"Bondaruk","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.eururo.2023.07.014_b0045","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/j.celrep.2019.01.095","article-title":"Whole-organ genomic characterization of mucosal field effects initiating bladder carcinogenesis","volume":"26","author":"Majewski","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.eururo.2023.07.014_b0050","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/JU.0000000000001878","article-title":"Urinary molecular pathology for patients with newly diagnosed urothelial bladder cancer","volume":"206","author":"Zhang","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.07.014_b0055","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2016.01.007","article-title":"Genomic alterations in liquid biopsies from patients with bladder cancer","volume":"70","author":"Birkenkamp-Demtr\u00f6der","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.07.014_b0060","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.eururo.2016.12.016","article-title":"Liquid biopsy analysis of FGFR3 and PIK3CA hotspot mutations for disease surveillance in bladder cancer","volume":"71","author":"Christensen","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.07.014_b0065","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.eururo.2022.09.008","article-title":"Elevated T-cell exhaustion and urinary tumor DNA levels are associated with bacillus Calmette-Gu\u00e9rin failure in patients with non-muscle-invasive bladder cancer","volume":"82","author":"Strandgaard","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.07.014_b0070","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/ncomms1814","article-title":"Reliable detection of subclonal single-nucleotide variants in tumour cell populations","volume":"3","author":"Gerstung","year":"2012","journal-title":"Nat Commun"},{"key":"10.1016\/j.eururo.2023.07.014_b0075","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1093\/bioinformatics\/btt750","article-title":"Subclonal variant calling with multiple samples and prior knowledge","volume":"30","author":"Gerstung","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.eururo.2023.07.014_b0080","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/ng.3441","article-title":"Clock-like mutational processes in human somatic cells","volume":"47","author":"Alexandrov","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.eururo.2023.07.014_b0085","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrc3817","article-title":"Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity","volume":"15","author":"Knowles","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.eururo.2023.07.014_b0090","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1200\/JCO.2005.06.081","article-title":"Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis","volume":"23","author":"Hicklin","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2023.07.014_b0095","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrd2488","article-title":"The TWEAK\u2013Fn14 cytokine\u2013receptor axis: discovery, biology and therapeutic targeting","volume":"7","author":"Winkles","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.eururo.2023.07.014_b0100","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/jcb.25496","article-title":"TGF-\u03b2 signaling in cancer","volume":"117","author":"Syed","year":"2016","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.eururo.2023.07.014_b0105","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","article-title":"CD8 T cell exhaustion during chronic viral infection and cancer","volume":"37","author":"McLane","year":"2019","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.eururo.2023.07.014_b0110","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/s41590-021-00975-5","article-title":"Epigenetic scarring of exhausted T cells hinders memory differentiation upon eliminating chronic antigenic stimulation","volume":"22","author":"Abdel-Hakeem","year":"2021","journal-title":"Nat Immunol"},{"key":"10.1016\/j.eururo.2023.07.014_b0115","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1158\/2159-8290.CD-18-0825","article-title":"Detection and surveillance of bladder cancer using urine tumor DNA","volume":"9","author":"Dudley","year":"2019","journal-title":"Cancer Discov"},{"key":"10.1016\/j.eururo.2023.07.014_b0120","doi-asserted-by":"crossref","first-page":"e1003732","DOI":"10.1371\/journal.pmed.1003732","article-title":"Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: a cohort study","volume":"18","author":"Chauhan","year":"2021","journal-title":"PLoS Med"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283823030142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283823030142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T13:14:12Z","timestamp":1759583652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283823030142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0302283823030142"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2023.07.014","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Field Cancerization Is Associated with Tumor Development, T-cell Exhaustion, and Clinical Outcomes in Bladder Cancer","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2023.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}